Cargando…
Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients
BACKGROUND: Chemotherapy is extensively used to treat breast cancer and is associated with skeletal muscle deconditioning, which is known to reduce patients' quality of life, treatment efficiency, and overall survival. To date, skeletal muscle mitochondrial alterations represent a major aspect...
Autores principales: | Mallard, Joris, Hucteau, Elyse, Charles, Anne‐Laure, Bender, Laura, Baeza, Claire, Pélissie, Mathilde, Trensz, Philippe, Pflumio, Carole, Kalish‐Weindling, Michal, Gény, Bernard, Schott, Roland, Favret, Fabrice, Pivot, Xavier, Hureau, Thomas J., Pagano, Allan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178151/ https://www.ncbi.nlm.nih.gov/pubmed/35373507 http://dx.doi.org/10.1002/jcsm.12991 |
Ejemplares similares
-
Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer
por: Mallard, Joris, et al.
Publicado: (2022) -
Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy
por: Hucteau, Elyse, et al.
Publicado: (2023) -
Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy
por: Mallard, Joris, et al.
Publicado: (2022) -
Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol
por: Mallard, Joris, et al.
Publicado: (2020) -
Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers
por: Mallard, Joris, et al.
Publicado: (2021)